These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 8381375

  • 1. Serum and tissue measurements of CA72-4 in ovarian cancer patients.
    Negishi Y, Iwabuchi H, Sakunaga H, Sakamoto M, Okabe K, Sato H, Asano G.
    Gynecol Oncol; 1993 Feb; 48(2):148-54. PubMed ID: 8381375
    [Abstract] [Full Text] [Related]

  • 2. [The clinical usefulness of serum CA72-4 analysis in patients with ovarian cancer].
    Kobayashi H.
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 May; 41(5):585-9. PubMed ID: 2754289
    [Abstract] [Full Text] [Related]

  • 3. CA54/61 as a marker for epithelial ovarian cancer.
    Nozawa S, Aoki D, Yajima M, Tsukazaki K, Kobayashi T, Kimura E, Terashima Y, Inaba N, Takamizawa H, Negishi Y.
    Cancer Res; 1992 Mar 01; 52(5):1205-9. PubMed ID: 1737381
    [Abstract] [Full Text] [Related]

  • 4. Tumor-associated glycoprotein (TAG-72) in ovarian carcinomas defined by monoclonal antibody B72.3.
    Thor A, Gorstein F, Ohuchi N, Szpak CA, Johnston WW, Schlom J.
    J Natl Cancer Inst; 1986 Jun 01; 76(6):995-1006. PubMed ID: 3520078
    [Abstract] [Full Text] [Related]

  • 5. [Studies on CA 125, CA 19-9, TPA and IAP as tumor markers in patients with ovarian cancer].
    Negishi Y, Furuno K, Sano Y, Hirata T, Utsunomiya A, Nakajima H, Okabe K, Shimizu K, Akiya K, Fujiwara Y.
    Gan No Rinsho; 1985 May 01; 31(6 Suppl):655-63. PubMed ID: 2993692
    [Abstract] [Full Text] [Related]

  • 6. Enhanced tumor binding using immunohistochemical analyses by second generation anti-tumor-associated glycoprotein 72 monoclonal antibodies versus monoclonal antibody B72.3 in human tissue.
    Molinolo A, Simpson JF, Thor A, Schlom J.
    Cancer Res; 1990 Feb 15; 50(4):1291-8. PubMed ID: 2297774
    [Abstract] [Full Text] [Related]

  • 7. [Value of the TAG-72 (CA 72-4) tumor marker in primary diagnosis of ovarian carcinoma. A comparison with the established CA-125 marker].
    Zeimet AG, Guadagni F, Marth C, Amato T, Müller-Holzner E, Huter O, Daxenbichler G, Dapunt O.
    Geburtshilfe Frauenheilkd; 1995 Apr 15; 55(4):195-9. PubMed ID: 7789707
    [Abstract] [Full Text] [Related]

  • 8. [Histological localization of TAG72 in gastric cancers and a clinico-pathological study of the CA72-4 serum values].
    Konishi F, Matzunou H, Konishi K, Yamamichi N.
    Gan No Rinsho; 1990 May 15; 36(6):691-9. PubMed ID: 2161468
    [Abstract] [Full Text] [Related]

  • 9. [Levels of circulating tumor-associated glycoprotein (TAG-72) in patients with carcinoma using a novel tumor marker, CA 72-4].
    Ohuchi N, Matoba N, Taira Y, Takahashi K, Sakai N, Sato K, Fujita N, Mochizuki F, Nishihira T, Mori S.
    Gan To Kagaku Ryoho; 1988 Sep 15; 15(9):2767-72. PubMed ID: 3166366
    [Abstract] [Full Text] [Related]

  • 10. [Analysis of CA 125 assay system and its diagnostic significance in gynecologic tumors].
    Shimizu Y, Akagaki E, Hirota K, Kono M, Miura S, Okudaira Y.
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec 15; 37(12):2813-20. PubMed ID: 3866801
    [Abstract] [Full Text] [Related]

  • 11. [The clinical significance of CA125 in patients with gynecological tumors--a comparative study on CA125 and other tumor markers].
    Suzumori K, Yasui Y, Asai H, Hisaoka T, Mizuno K, Yagami Y.
    Gan No Rinsho; 1985 May 15; 31(5):544-8. PubMed ID: 3860666
    [Abstract] [Full Text] [Related]

  • 12. [Relationship between serum levels and immunohistological tissue levels of CA 125 and CEA in epithelial ovarian cancers: its implications for tumor cell type specificity].
    Oishi T, Maruo T, Iwasaki M, Mochizuki M.
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Sep 15; 38(9):1595-604. PubMed ID: 3464659
    [Abstract] [Full Text] [Related]

  • 13. [Sharing antigenic determinant of colon carcinoma between serous and mucinous tumors of the ovary].
    Liu MP, Lu ZT, Chen W.
    Zhonghua Fu Chan Ke Za Zhi; 1994 Jul 15; 29(7):398-400, 444. PubMed ID: 7528120
    [Abstract] [Full Text] [Related]

  • 14. Characteristic mucinous ovarian cancer antigen is expressed in malignantly transformed Bloom's syndrome cells.
    Shiraishi Y, Yamamoto K, Soma H.
    Cancer Res; 1993 Jul 15; 53(14):3427-32. PubMed ID: 8391927
    [Abstract] [Full Text] [Related]

  • 15. The value of epithelial membrane antigen in the diagnosis of ovarian tumors.
    Fujimoto I, Hirai Y, Hasumi K, Masubuchi K, Osamura Y.
    Acta Cytol; 1990 Jul 15; 34(4):549-54. PubMed ID: 1695804
    [Abstract] [Full Text] [Related]

  • 16. Increased serum 72 KDa metalloproteinase in serous ovarian tumors: comparison with CA 125.
    Garzetti GG, Ciavattini A, Lucarini G, Goteri G, Romanini C, Biagini G.
    Anticancer Res; 1996 Jul 15; 16(4A):2123-7. PubMed ID: 8712754
    [Abstract] [Full Text] [Related]

  • 17. Immunological reactivity of mucinous and serous ovarian adenocarcinomas.
    Harłozińska-Szmyrka A, Slesak B, Richter R, Rabczyński J, Cisło M.
    Cancer Detect Prev; 1986 Jul 15; 9(3-4):347-58. PubMed ID: 3017557
    [Abstract] [Full Text] [Related]

  • 18. Tumor-associated antigen Ca 125 before and during the treatment of ovarian carcinoma.
    Kivinen S, Kuoppala T, Leppilampi M, Vuori J, Kauppila A.
    Obstet Gynecol; 1986 Apr 15; 67(4):468-72. PubMed ID: 3008051
    [Abstract] [Full Text] [Related]

  • 19. Reactivity of monoclonal antibody DF3 with a high molecular weight antigen expressed in human ovarian carcinomas.
    Friedman EL, Hayes DF, Kufe DW.
    Cancer Res; 1986 Oct 15; 46(10):5189-94. PubMed ID: 3530435
    [Abstract] [Full Text] [Related]

  • 20. Relationship of serum CA125 and lipid-associated sialic acid tumor-associated antigen levels to the disease status of patients with gynecologic malignancies.
    Stratton JA, Rettenmaier MA, Phillips HB, Herabutya S, DiSaia PJ.
    Obstet Gynecol; 1988 Jan 15; 71(1):20-6. PubMed ID: 2827081
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.